Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias

About Alzheimer's

Pressing need for effective therapies

Alzheimer's disease remains one of the greatest societal and economic challenges of our time. It is estimated that there are over six (6) million people living with Alzheimer’s Disease in the US, and this number is expected to double by 2050.

Who We Are

Monument Biosciences is dedicated to bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD). Our team is comprised of leading neuro focused scientists, clinicians, and entrepreneurs.

Our mindset

Innovating in ADRD

We are here to advance a new generation of AD targets that push the frontiers of research that can translate to meaningful improvements in lives of patients and their families.  

To accomplish that vision we are exploring diverse therapeutic modalities and potential combination therapy – what we believe to be the future of research and patient care in ADRD and neurodegeneration.

Our approach

Process proved by experience

Our discovery programs are anchored in human patient genetics, recent discoveries around tau homeostasis and tau seeding, and the role of microglia in neuroinflammation.

Our approach relies on translational biomarkers to treat the right patients and follow their disease progress in response to therapy – informing clinical strategy, safety, and patient benefit.    

Get in touch

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.